Janney Montgomery Scott LLC Raises Position in SPDR S&P Biotech ETF (XBI)

Janney Montgomery Scott LLC increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 108,778 shares of the exchange traded fund’s stock after acquiring an additional 7,675 shares during the period. Janney Montgomery Scott LLC owned approximately 0.20% of SPDR S&P Biotech ETF worth $10,355,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of XBI. Bank of New York Mellon Corp boosted its stake in shares of SPDR S&P Biotech ETF by 12.1% in the 4th quarter. Bank of New York Mellon Corp now owns 21,214 shares of the exchange traded fund’s stock valued at $1,801,000 after purchasing an additional 2,282 shares in the last quarter. Macquarie Group Ltd. boosted its position in SPDR S&P Biotech ETF by 126.5% during the 4th quarter. Macquarie Group Ltd. now owns 28,539 shares of the exchange traded fund’s stock valued at $2,422,000 after buying an additional 15,939 shares during the period. Envestnet Asset Management Inc. boosted its position in SPDR S&P Biotech ETF by 739.3% during the 4th quarter. Envestnet Asset Management Inc. now owns 55,539 shares of the exchange traded fund’s stock valued at $4,712,000 after buying an additional 48,922 shares during the period. Ashfield Capital Partners LLC purchased a new stake in SPDR S&P Biotech ETF during the 1st quarter valued at $902,000. Finally, Appleton Group LLC boosted its position in SPDR S&P Biotech ETF by 15.6% during the 1st quarter. Appleton Group LLC now owns 9,525 shares of the exchange traded fund’s stock valued at $836,000 after buying an additional 1,286 shares during the period.

Shares of XBI opened at $94.95 on Friday. SPDR S&P Biotech ETF has a twelve month low of $74.35 and a twelve month high of $101.55.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: Growth Stocks, What They Are, What They Are Not

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply